Showing results (181-190 of 305) with videos related to
Sort By:
Pageof 31
Toxicology and Applied Pharmacology|June 19, 1998
Toxicology and pharmacokinetics of DT388-GM-CSF, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony-stimulating factor (GM-CSF) in C57BL/6 miceP D Hall, R J Kreitman, M C Willingham, et al.Leukemia|April 24, 1999
DT388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocyte-macrophage colony-stimulating factor, prolongs host survival in a SCID mouse model of acute myeloid leukemiaP D Hall, M C Willingham, R J Kreitman, et al.Hepatology (Baltimore, Md.)|May 1, 1991
Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the ratP D Hall, J L Plummer, A H Ilsley, et al.Anesthesiology|September 1, 1987
Hepatic effects of repeated halothane anesthetics in the hypoxic rat modelJ L Plummer, P D Hall, M A Jenner, et al.Hepatology (Baltimore, Md.)|April 1, 1990
Autoantibodies to isolated human hepatocyte plasma membranes in chronic active hepatitis. II. Specificity of antibodiesN R Swanson, W D Reed, L J Yarred, et al.Immunology|March 1, 1991
Murine anti-cytomegalovirus monoclonal antibodies with autoreactivityC M Lawson, H L O'Donoghue, H E Farrell, et al.Hepatology (Baltimore, Md.)|May 1, 1986
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosisW G Cooksley, R A Bradbear, W Robinson, et al.Arthritis and Rheumatism|October 1, 1990
Renal disease in chronic arthritis of childhood. A study of urinary N-acetyl-beta-glucosaminidase and beta 2-microglobulin excretionP N Malleson, G Lockitch, M Mackinnon, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 1, 1995
Standardization of flow cytometric crossmatch (FCXM) for investigation of unexplained habitual abortionM D Stephenson, V Wu, M Mackinnon, et al.Australian and New Zealand Journal of Medicine|February 1, 1990
Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis BS J Williams, P I Craig, W G Cooksley, et al.Pageof 31